🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests how well elacestrant with everolimus works for th...
Status
Not Yet Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2026-12-18
Trial ID
NCT07634601
The purpose of this study is to visualize and quantify ER-binding sites dur...
Status
Completed
Location
Institut Jules Bordet
Start Date
2016-04-01
Trial ID
NCT02650817
Treatments Being Tested
The goal of this research study is to compare a combination of two drugs, c...
Status
Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2026-01-16
Trial ID
NCT07222215
Treatments Being Tested
The goal of this study is to evaluate the safety and efficacy of elacestran...
Status
Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2025-11-17
Trial ID
NCT07198724
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of cardiac...
Status
Withdrawn
Location
University of Alabama at Birmingham (UAB) Department of Radiation Oncology
Start Date
2022-11
Trial ID
NCT04757688
Treatments Being Tested
This is an international, multisite, open-label, Phase 1b/2 study, to confi...
Status
Completed
Location
Site 38 - Northwestern University, Feinberg School of Medicine, Northwestern University
Start Date
2023-10-09
Trial ID
NCT05963997
Treatments Being Tested
This Phase 3 clinical study compares the efficacy and safety of elacestrant...
Status
Completed
Location
The University of Arizona Cancer Center
Start Date
2019-05-10
Trial ID
NCT03778931
Treatments Being Tested
This study is to evaluate the efficacy and safety of elacestrant, in partic...
Status
Recruiting
Location
Dana Farber Cancer Institute
Start Date
2026-03-25
Trial ID
NCT07467772
Treatments Being Tested